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Background: Wounds can easily become chronically infected, leading to secondary health complications, which occur
more frequently in individuals with diabetes, compromised immune systems, and those that have suffered severe
burns. When wounds become chronically infected, biofilm producing microbes are often isolated from these sites.
The presence of a biofilm at a wound site has significant negative impact on the treatment outcomes, as biofilms are
characteristically recalcitrant to removal, in part due to the formation of a protective matrix that shield residents
organisms from inimical forces. Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) are two
of the organisms most prevalently isolated from wound sites, and are of particular concern due to their elevated levels
of antibiotic resistance, rapid growth, and exotoxin production. In order to understand the biofilm forming abilities of
these microbes in a simulated wound environment we used a microtiter plate assay to assess the ability of these two
organisms to bind to proteins that are typically found at wound sites: collagen and hyaluronan.
Results: Collagen and hyaluronan were used to coat the wells of 96-well plates in collagen:hyaluronan ratios of 0:1, 3:1,
1:1, 1:3, and 1:0 . P. aeruginosa and MRSA were inoculated as mono- and co-cultures (1:1 and a 3:1 MRSA: P. aeruginosa).
We determined that coating the wells with collagen and/or hyaluronan significantly increased the biofilm biomass of
attached cells compared to an uncoated control, although no one coating formulation showed a significant increase
compared to any other combination. We also noted that the fold-change increase for MRSA upon coating was greater
than for P. aeruginosa.
Conclusions: Our study suggests that the presence of collagen and/or hyaluronan at wound sites may be an
important factor that influences the attachment and subsequent biofilm formation of notorious biofilm-formers, such
as MRSA and P. aeruginosa. Understanding the kinetics of binding may aid in our comprehension of recalcitrant wound
infection development, better enabling our ability to design therapies that would prevent or mitigate the negative
outcomes associated with such infections.
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The treatment and management of chronic wounds rep-
resents a significant burden to both healthcare systems
and patients [1-3]. The treatment of chronic wounds is
costly; treatment of leg ulcers in North America can cost
up to US$ 45, 000 for patients [3]. This does not account
for deleterious effects on the quality of the patient’s life* Correspondence: sneethir@uoguelph.ca
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article, unless otherwise stated.[3]. Most chronic wounds arise from amputation, burns,
or venous ulcers and can become exacerbated in the
case of immunocompromised, obese, or diabetes melli-
tus patients [4-6]. Underlying layers of cutaneous tissue
can become exposed to opportunistic and pathogenic
microbes at wound sites. The release of the cytoplasmic
contents from damaged cells makes this a nutrient-rich
environment that is highly susceptible to infection from
the patient’s endogenous microbiota, the environment or
from healthcare providers [7].ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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that many organisms exist as a biofilm community, which
diverges from earlier microbial theorem that postulates
microorganisms operate as individual cells [8]. Today, we
recognize that the vast majority of microbes are found in
dynamic complex communities, which include polymicro-
bial biofilms [9-11]. Common constituents of polymicrobial
wound biofilms include methicillin-resistant Staphylococcus
aureus (MRSA) and Pseudomonas aeruginosa with many
studies examining the dynamics of these microbes [12,13].
MRSA and P. aeruginosa readily colonize wound sites,
forming biofilms that are resistant to antibiotics, phago-
cytes, and other immune system components, such as anti-
bodies and complement proteins [4-7,14,15]. Recently, S.
aureus and P. aeruginosa have been implicated in produ-
cing and secreting human surfactant proteins which may
explain their aggressive colonization and biofilm produc-
tion in the lungs of cystic fibrosis patients [16].
P. aeruginosa is a prolific biofilm former, producing bio-
films within as little as 10 hours in vitro [17]. Studies show
that the major mechanism of attachment involves type IV
pili; cells initially attach reversibly via pili and eventually
become irreversibly attached, leading to the loss of pili [8].
P. aeruginosa is a common inhabitant of soil environments
and can be found on the skin [13]. Although it is com-
monly not harmful to healthy individuals, it is a voracious
opportunistic pathogen with a high-affinity for water
and will frequently occupy mucosal surfaces [13,18-20]. P.
aeruginosa has been implicated in less severe cases of
dermatitis, but infection may become serious in cutaneous
infections of immunocompromised patients [13]. In mi-
crobial biofilm communities, P. aeruginosa increases bio-
film virulence by cooperatively helping the growth of other
microorganisms [13,21]. P. aeruginosa is a siderophore-
producing bacterium, which allows it to scavenge iron,
a growth limiting nutrient, from erythrocytes present at
wound sites [21]. In many cases, non-siderophore produ-
cing microorganism, such as S. aureus, are able to scav-
enge P. aeruginosa’s siderophores, leading to higher levels
of microbial growth [21].
Staphylococcus aureus is a transient colonizer of the
nasal passages and is carried asymptomatically in the
nasopharynx of 35% to 60% of the human population
[13]. It too, like P. aeruginosa, is an opportunistic patho-
gen and the causative agent of many self-limiting skin
infections [13]. However, if infection from S. aureus
persists, more serious complications may occur such as
cellulitis, bacteremia, pneumonia, and toxic shock. The
most common sites of S. aureus infection include the
skin and soft tissues [13]. To that effect, 75% of soft
tissue infections are caused by the methicillin-resistant
Staphylococcus aureus (MRSA), S. aureus that is resist-
ant to all β–lactam antibiotics by virtue of acquisition of
mecA and which often acquires resistance to otherantimicrobial classes [13,22]. MRSA is non-motile and does
not produce surface appendages, such as pili (as observed
with P. aeruginosa). Instead MRSA uses surface proteins
such as ClfB and Eap and relies on surface charges in order
to mediate adherence to squamous epithelial cells [23-25].
In order to better understand how P. aeruginosa and
MRSA form biofilms at wound sites, it is critical to under-
stand the overall dynamics of the wound environment.
Collagen and hyaluronan are two common proteins found
in the skin, and both excellent candidates for the gener-
ation of skin substitutes [26,27]. Both are found in the der-
mal region of the skin, which is mostly acellular, consisting
of collagen, elastin, and hyaluronan (among other glycos-
aminoglycans) [28]. This is the opposite of the epidermis,
which is composed of up to 95% keratinocytes [28]. Colla-
gen, elastin, and hyaluronan compose the dermal extracel-
lular matrix in which fibroblasts and macrophages reside
[28]. Collagen is the main component of connective tissue
and functions as a support for tissue growth and acts as
a chemo-attractant and scaffold for keratinocyte and
fibroblast cells [29,30]. Hyaluronan is a common com-
ponent of all extracellular matrices and is involved in
regulation of cell function, migration, proliferation, and
differentiation [31].
The collagen and hyaluronic acid ratio vary between indi-
vidual’s age and sex. Collagen accounts for 70% of dermis
[32], while hyaluronic acid forms a smaller part of the der-
mis. The amount of hyaluronic acid is about 0.1 to 0.2
microgram/milligram dry weight of the dermis [32]. Col-
lagen is cationic but hyaluronan is anionic, and hence the
two macromolecules may form polyionic complexes in
aqueous solution [33]. Higher hyaluronic acid concentration
in the cross-linked collagen-hyaluronan matrix may lead to
higher stiffness and higher bulk modulus in the skin.
Due to their likely importance in chronic wound infec-
tions, we examined the interactions among collagen, hya-
luronan, MRSA, and P. aeruginosa. As anticipated, we
found that the presence of collagen and hyaluronan influ-
ences the early adhesive events that are critical for the es-
tablishment of potentially life threatening MRSA and P.
aeruginosa infections. Ultimately, we found that although
differences in the formulations of these components did
not affect biofilm formation, the presence of any formula-
tion (each alone or together in different ratios) signifi-
cantly increased the biofilm biomasses of both MRSA and
P. aeruginosa. Our results support the notion that collagen
and hyaluronan may be important ligands for microbial at-
tachment. Understanding the dynamics of binding may
lead to improved therapies that target adhesion.
Methods
Bacterial strains
Bacterial strains used in this study consisted of MRSA and
Pseudomonas aeruginosa. Two strains of each microbe
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were obtained from canine ear skin infections. MRSA
M05-35 (USA 100) and MRSA M05-86 (USA 300) were
obtained from human skin infections.
Culture conditions
MRSA and P. aeruginosa strains were streaked onto 5%
sheep blood agar (SBA) plates from −80°C frozen stocks,
and were grown inverted at 37°C for 24 hours. For micro-
titer plate and AFM experiments, cultures were grown in
5 mL tryptic soy broth (TSB) at 37°C for 24 hours.
Microtiter plate assay
Collagen and hyaluronan coating
Standard 96-well polystyrene microtiter plates were
coated with rat-tail collagen type I (BD Biosciences) and
hyaluronan (0.05 mg/ml, Sigma) both dissolved in 0.9%
NaCl solutions at concentrations of 50 μg/mL, similar to
the protocol carried out by Werthen et al. [34]. Wells
consisted of 1:0, 3:1, 1:1, 1:3, and 0:1 collagen:hyaluronan
coatings in replicates of four along with a replicates of
uncoated wells. To each well, a total of 300 μL of solu-
tion was added. Plates were then covered and allowed to
incubate at 4°C for 24 hours. Coating solutions were
gently removed after this time and the wells were rinsed
twice with a 0.9% NaCl solution.
Inoculation and incubation
Single colonies from SBA plates were cultured in 5 mL
of TSB and were allowed to grow for 24 hours at 37°C
in a reciprocal shaker (200 rpm). Cultures were stan-
dardized to ~1.5 × 108 CFU/ml in TSB (supplemented
with 0.1% NaCl) using a 0.5 McFarland standard. For
mono-cultures, 200 μL was inoculated in replicates of
four to the coated and uncoated wells. For 1:1 co-
cultures, 100 μL of MRSA and 100 μl of PA were inocu-
lated in replicates of four to the coated and uncoated
wells. For the 3:1 MRSA:PA co-culture, 150 μL of MRSA
and 50 μL of PA were inoculated in replicates of four to
the coated and uncoated wells. Controls were prepared
and incubated alongside the microtiter plate assay and
underwent the same subsequent treatments (heat-fixing,
crystal violet staining, etc.). No contamination was ap-
parent in the negative controls (no opacity/turbidity).
Average OD values obtained from the controls were
subtracted from the corresponding experimental values
obtained. Microtiter plates were incubated for 24 hours
at 37°C under static conditions in order to allow for bio-
film formation [34,35].
Quantification of biofilms
The quantification of biofilms was done using a modi-
fied protocol of Singh et al. [36]. After 24 hour growth
in microtiter plates, microbial solutions were discarded.Wells were washed three times with 200 μL PBS (pH =
7.2) in order to remove unattached cells. Biofilms were
then heat-fixed at 60°C for 60 minutes and were subse-
quently stained with 0.1% crystal violet for 15 minutes at
room temperature. Crystal violet was aspirated with a
pipette, and the plates were rinsed by submersion in a
container of tap water. Plates were then allowed to dry
for 60 minutes at 35°C. After this the stained biofilms
were re-solubilized in 200 μL of 95% ethanol and OD
was taken at 562 nm.
Selective dilution plating
In order to enumerate the number of viable microbial cells
in mono- and co-cultures, selective dilution plating experi-
ments were performed. Mono-cultures were grown in
TSB (supplemented with 0.1% NaCl) for 24 hours at 37°C
in a reciprocal shaker (200 rpm). Mono-cultures were then
standardized to a 0.5 McFarland standard. 1 mL of each
standardized mono-culture was then inoculated into sep-
arate test tubes containing 6 mL of fresh TSB broth. For
the 1:1 co-culture, 1 mL of each mono-culture was inocu-
lated into the same test tube containing 6 mL of fresh
TSB. For the 3:1 MRSA:PA co-culture, 1.5 mL and 0.5 mL
of MRSA and P. aeruginosa strains were inoculated into
6 mL of fresh TSB. These three cultures were then grown
for 24 hours under the same conditions as previously
mentioned. After 24 hours, 1 mL from each culture (PA-76,
MRSA-35, and PA-76 +MRSA-35) was inoculated into
separate 9 mL PBS (pH= 7.4) test tubes to create 10−1 di-
lutions. From this, 1 mL was transferred to 9 mL of PBS
to create the next dilution. This process was repeated until
10−7 dilutions were generated. 0.1 mL from each dilution
was then plated and grown for 24 hours at 37°C. Mono-
cultures were plated on 5% SBA. Co-cultures were plated
on Pseudomonas CFC Agar (Oxoid) and Staphylococcus
Medium 110 (Oxoid) in order to select for P. aerugionsa
and MRSA respectively. Plates containing 25–250 colonies
were used in determining bacterial CFU/mL.
Atomic force microscopy
Single colonies of MRSA M05-35 and PA BK-76 were in-
oculated into separate test tubes containing 5 mL TSB
each. A co-culture was generated by inoculating single
colonies of these strains into the same test tube containing
5 mL TSB. These were grown for 24 hours at 37°C. After
this time 1 mL from each culture was centrifuged at
1200 rpm for 3 minutes and washed twice with deionized
water. 200 μL of the washed cell solutions was pipetted
onto mica sheets pre-coated with gelatin (0.005 g/mL). A
gelatin pre-coating was done in order to improve cell to
surface attachment [37]. Cultures were allowed to sit on
the mica sheets for 30 minutes before being rinsed off
with 1 mL of deionized water. After rinsing, the mica
sheets were covered and allowed to dry overnight. Imaging
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mode) in air.
Negative controls
Negative controls for the microtiter plate assay consisted
of inoculating TSB (replicates of four) into the coated
(collagen:hyaluronan in varying ratios as describe above)
and uncoated wells. For the selective dilution plating, 0.1 mL
of the PA-76 and MRSA-35 (100 dilutions) were inocu-
lated onto Staphylococcus Medium 110 and Pseudomonas
CFC Agar, respectively. No growth was observed after
24 hours at 37°C.
Statistical methods
Experiments were conducted in triplicate and repeated
twice. A student’s t-test was performed to compare groups
with a P < 0.05 being considered significant. Statistical
analysis was performed on commercially available software
(R Open Source Statistical Programming).
Results and discussion
Coating with collagen and hyaluronan increases P.
aeruginosa and MRSA attachment
When we examined P. aeruginosa BK-68 (PA-68) biofilm
growth on coated vs. uncoated surfaces, we found that
coated wells harbored more biomass after a 24 h incuba-
tion; however, not to a significant extent in most cases
with the exceptions being the 3:1 hyaluronan:collagen
and the collagen coatings (P = 0.02 and P = 0.02 respect-
ively) (Figure 1). Among the coated wells, the 3:1 colla-
gen: hyaluronan well led to the highest biofilm growth
with an absorbance of 1.73. The lowest absorbance
among the coated wells occurred in the 1:1 collagen: HA
coated well, with an absorbance reading of 1.39.
Similar to strain PA-68, P. aeruginosa BK-76 (PA-76)
biofilm production was again enhanced in coated wells;
however, not to a significant extent in most cases. Ex-
ceptions here this time were seen with the collagen and
hyaluronan coated wells (P = 0.03 and P = 0.04 respect-
ively). The greatest production occurring in the collagen
coated well (Abs = 3.71). The lowest biofilm production
in the coated wells was observed in the 1:1 collagen: HA
well (Abs = 2.66), similar to PA-68. Between well coat-
ings, no significant differences in biofilm biomass pro-
duction were observed in both P. aeruginosa strains.
This suggests that none of the coatings combinations in
particular promoted greater or lesser biofilm biomass.
Coatings also increased biofilm formation in MRSA
M05-35 (MRSA-35) and MRSA M05-86 (MRSA-86)
(Figure 1) after 24 h of growth; however, in this case all
coating showed a significant increase in biofilm formation
compared to the uncoated wells (P < 0.05). For both MRSA
strains, the collagen wells showed the greatest significant
difference compared to the uncoated wells (P < 0.001 inboth cases). For MRSA-35 all collagen:hyaluronan wells
showed significantly less biofilm biomass than the hyaluro-
nan coated well (P < 0.05). This was not observed when
comparing the collagen and hyaluronan coated wells with
the collagen well showing greater biofilm biomass produc-
tion, but not to a significant extent. Among well coatings
for MRSA-86, a significant decrease in biofilm biomass
was observed in 1:1 collagen: hyaluronan and 3:1 hyaluro-
nan:collagen wells compared to the collagen well (P =
0.002 and P = 0.005 respectively).
Ultimately, we determined that collagen coating by itself
appears to be the most effective substrate for biofilm at-
tachment. We found it interesting that HA alone or the
addition of HA to collagen did little to alter the biofilm
attachment phenotype, considering that it is frequently
present at the wound site [38]. This data suggests that
these important wound infection pathogens (particularly
MRSA) may have a preference for binding to skin and
wound proteins [34]. At this time, we do not know if that
is preferential binding is dictated by specific ligands or
whether the interaction is governed by the intrinsic phys-
ical properties of collagen.
The significant increase in biofilm production from both
MRSA strains between coated and uncoated wells is be-
lieved to be due to MRSA’s less efficient ability, compared
to P. aeruginosa, to attach and adhere to surfaces, a vital
component in the formation of biofilms [12,39-41]. The en-
hancement in biofilm formation upon coating of the wells
was less dramatic for P. aeruginosa. We believe this may be
because P. aeruginosa is efficient at adhering to nearly any
surface, including polystyrene [40,42,43]. P. aeruginosa is
known to have more effective methods of attachment and
adherence to surfaces, most notably through type IV pili
(TFP), whereas S. aureus relies mainly on surface protein-
protein interactions for attachment [23,24,41,44-46]. Specif-
ically Eap, ClfB, and teichoic acid, all of which are S. aureus
membrane proteins, have been implicated as key proteins
for initial attachment [23,24,41]. Other adhesive factors as-
sociated with Staphylococcal microbial attachment include
eDNA, accumulation-associated proteins (Aaps), phenol-
soluble modulins (PSMs), polysaccharide intracellular adhe-
sins (PIAs), and microbial surface components recognizing
adhesive matrix molecules (MSCRAMMs) [47]. The net
cell surface charge of S. aureus, as well as surface porosity
itself has been shown to significantly affect initial cell
attachment [40,41]. It was shown that among MRSA
mono-cultures, any coating combination helped improve
the attachment and adherence. This is significant as these
proteins are commonly found in the natural wound envir-
onment and have previously been shown to promote at-
tachment and adherence of many microorganisms [34,38].
PA-68 and PA-76 are relatively newly isolated strains
and have not yet been fully characterized through genomic
and proteomic analysis. The difference in the binding
Figure 1 Collagen and Hyaluronan enhance Biofilm Production in P. aeruginosa and MRSA Mono-cultures. Biofilm production as
observed at OD = 562 nm after crystal violet microtiter plate assay among P. aeruginosa (PA-68, PA-76) and MRSA (MRSA-35, MRSA-86). The various
protein ratios/well coatings are shown in the x-axis with HA representing hyaluronan. Error bars shown represent the 1 standard deviation values
for each sample.
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to the differences in the Type IV pilus or the fimL genes be-
tween them [48]. However additional studies are warranted
to characterize the binding profiles of these two pseudo-
monas strains. There are 228 genes present in USA300
(MRSA M05-86) strain but not in USA100 (MRSA M05-35)
of the Staphylococcus aureus [49]. Lack of cell surface
adhesion genes such as fnbA, fnbB and ebh in USA100
but their presence in the USA300 [49] could be the reason-
ing behind the binding activity differences of MRSA-35 and
MRSA-86 on collagen and hyaluronan surfaces.
Co-culture biofilms possess less biomass, denoting a
possible competitive interaction between P. aeruginosa
and MRSA
We grew co-cultures of P. aeruginosa and MRSA to deter-
mine the impact on biofilm formation. 1:1 co-cultures were
examined first (Figure 2). These were grown in coated and
uncoated wells to assess the impact of coating on biofilm
formation. Compared to P. aeruginosa and MRSA-35 (the
highest biofilm producing microbes/strains in monocul-
ture), all 1:1 co-cultures produced significantly less biofilm
when comparing similar coating types (P < 0.05) with the
exception of the MRSA-35 in the 1:1 collagen:hyaluronan
compared with the PA-76/MRSA-35 co-culture in the 1:1
collagen:hyaluronan well (P = 0.53).
Between the various well coatings, no significant differ-
ence in biofilm biomass was observed between any of the
wells in the PA-68/MRSA-35 and PA-68/MRSA-86 co cul-
tures. Among the PA76/MRSA-35 co-culture, the collagen
coating led to significantly higher biofilm biomass com-
pared to the hyaluronan and uncoated wells (P = 0.04 and
P = 0.001 respectively). This was also observed between
the 3:1 collagen:hyaluronan and hyaluronan and uncoated
wells (P = 0.04 and P = 0.002 respectively). It was alsoobserved that the 1:1 collagen: hyaluronan well led to
significantly higher biofilm biomass compared to the 3:1
collagen: hyaluronan, 3:1 hyaluronan:collagen, hyaluronan,
and uncoated wells for the PA76/MRSA-35 co-culture
(P < 0.05). Overall, the 1:1 collagen: hyaluronan well led to
the highest biofilm biomass in the PA-76/MRSA-35 co-
culture. Among the PA-76/MRSA-86 co-culture, signifi-
cantly less biofilm biomass was produced in the hyaluro-
nan well compared to the collagen well (P = 0.01).
These results imply that coating type was less relevant
to biofilm production in 1:1 co-cultures as competition ef-
fects between P. aeruginosa and MRSA likely dominated
and subsequently hindered biofilm production. It has been
established that P. aeruginosa, in-vitro, negatively affects
the attachment and growth of staphylococcal species,
[43,50-52] something that could also be reflected in de-
creased biofilm production. These results are in keeping
with the expected outcomes. It has been shown that in co-
culture, both S. aureus and PA produce ‘thinner’ biofilms
compared to their mono-culture biofilms [39]. This points
to a competitive interaction between the two species,
likely for nutrients and co-factors, such as iron, as well as
for a niche to occupy, as they may compete for binding
sites. The production and release of chemical signals, me-
tabolites, and volatile compounds from P. aeruginosa have
been implicated in affecting the growth and biofilm pro-
duction of other microbes [53]. Most notably cyanide-like
compounds such as pyocyanin, have been implicated in
arresting S. aureus growth through inhibition of cellular
cytochromes necessary for S. aureus’ respiratory cycle
[39,54]. These compounds can become concentrated in
closed in vitro experiments (microtiter plate well) leading
to the decreased viability of S. aureus [54]. Even though P.
aeruginosa inhibits MRSA growth, it does not completely
prevent it from forming biofilms as these two microbes
Figure 2 Biofilm production in 1:1 co-cultures after 24 hours. Biofilm production as observed at OD = 562 nm after crystal violet microtiter
plate assay among P. aeruginosa (PA-68, PA-76) and MRSA (MRSA-35, MRSA-86). Co-cultures included PA-68/MRSA-35, PA-68/MRSA-86, PA-76/
MRSA-35, and PA-76/MRSA-35. The various protein ratios/well coatings are shown in the x-axis with HA representing hyaluronan. Error bars shown
represent the 1 standard deviation values for each sample.
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shown that P. aeruginosa type IV pili are essential for the
process of S. aureus microcolony formation, an important
component of biofilm adherence [43]. P. aeruginosa has
also been shown to protect S. aureus against phagocytic
cells such as Dictyostelium discoideum in co-culture bio-
films [43].
After determining that a 1:1 ratio of P. aeruginosa to
MRSA inhibited biofilm formation, we tried a 3:1 co-
culture of the MRSA: P. aeruginosa to determine if a
greater MRSA cell number could help to overcome these
inhibitory effects (Figure 3). Biofilm formation was reduced
in 3:1 cultures compared to mono-culture regardless of
well coating. Compared to 1:1 co-culture biofilms, the
3:1 co-cultures showed few significant differences in the
amount of biofilm biomass. Exceptions included a signifi-
cant decrease in biofilm biomass between the PA-68/
MRSA-35 co-culture and the 3:1 MRSA-35/PA-68 co-
culture in the 3:1 hyaluronan: collagen wells (P = 0.04).
Among the 3:1 MRSA-35/PA-76 co-culture a significant
increase in biofilm biomass was observed compared to
the PA-76/MRSA-35 co-culture in the collagen wells
(P = 0.02). Other notable difference occurred between the
3:1 MRSA-86/PA-68 and PA-68/MRSA-86 co-cultures,
with a significant decrease in biofilm formation among the
3:1 collagen:hyaluronan, 1:1 collagen/hyaluronan, 3:1 hya-
luronan:collagen, and uncoated wells in the 3:1 co-culture
(P < 0.05). Even though some significant differences existed,
there was no overall trend that led us to believe there was
an overall difference in biofilm biomass production be-
tween the two co-culture types.
Similar to the 1:1 co-cultures, in the 3:1 co-cultures,
no unifying trend was observed in which one particular
well coating led to significantly higher biomass even
though some statistically significant differences existed.Again, similar to the 1:1 co-cultures, these results imply
that the coating type was less relevant to biofilm produc-
tion in 1:1 co-cultures as the competition effects be-
tween P. aeruginosa and MRSA likely dominated and
subsequently hindered biofilm production.Co-culturing led to a decrease in the number of viable
P. aeruginosa and MRSA cells
A selective dilution plating experiment was performed in
order to determine the effects of co-culturing on cell num-
bers (Figures 4, 5 and 6). P. aeruginosa and MRSA both
grew well in mono-cultures, with MRSA strains showing
higher CFU/mL counts. From this it is apparent that
MRSA grew to higher numbers after 24 hours than PA.
Co-culturing (in 1:1 and 3:1 MRSA:PA ratios) led to large
decrease in microbial CFU/mL values with MRSA appear-
ing to be the most effected from co-culturing. Increasing
the inoculum count of MRSA to 3x that of P. aeruginosa
led to increased MRSA counts when compared to 1:1
co-cultures; however, higher MRSA inoculations did not
bring MRSA counts back to mono-culture levels. Likewise,
P. aeruginosa cell counts were shown to be more affected
in 3:1 co-cultures. These results indicate that upon co-
culturing microbial numbers for both species decrease
significantly with MRSA being affected the most. The
competitive effects between these microbes leads to a sig-
nificant decreases in viable cell counts and may provide
another explanation for the poor biofilm production seen
in 1:1 and 3:1 MRSA:PA co-cultures (Figures 2 and 3).
The reduction in MRSA cells upon co-culturing indicates
that P. aeruginosa greatly affects MRSA cell viability. Al-
though P. aerugionsa grew slowly than MRSA in mono-
culture, P. aeruginosa cell counts were less affected from
co-culturing.
Figure 3 Biofilm production in 3:1 MRSA:P. aeruginosa co-cultures after 24 hours. Biofilm production as observed at OD = 562 nm after
crystal violet microtiter plate assay among P. aeruginosa (PA-68, PA-76) and MRSA (MRSA-35, MRSA-86). 3:1 Co-cultures included MRSA-35/PA-68,
MRSA-35/PA-76, MRSA-86/PA-68, and MRSA-86/PA-76. The various protein ratios/well coatings are shown in the x-axis with HA representing
hyaluronan. Error bars shown represent the 1 standard deviation values for each sample.
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result of cell lysis
We obtained atomic force microscopy (AFM) images of
PA-76, MRSA-35, and a co-culture of PA-76/MRSA-35
biofilms, as these strains/combinations produced the
greatest overall biofilm biomasses. We used imaging to
monitor the overall appearance of the cells and integrity
of their membranes to assess whether molecules pro-
duced in co-culture were damaging the cells and/or
causing apoptosis. In the PA-76 mono-culture, the cell
membranes were intact with little to no damage to the
cells (Figure 7). In terms of cell morphology, there were
no obvious defects in cell shape or size for mono-cultureFigure 4 Quantitative bacteriology of mono-culture P. aeruginosa and
were quantified from growth in mono-cultures to be compared and contra
MRSA strains showed higher CFU/mL values than P. aeruginosa strains. Col
(4.1 x 109 CFU/mL), MRSA-86 (3.9 x 109 CFU/mL), PA-68 (2.73 x 109 CFU/mgrown P. aeruginosa cells. P. aeruginosa was seen as ei-
ther single cells, doubles (attached in some cases, maybe
in the midst of cell division), and as densely packed ag-
gregates of 5 or more cells. Flagella were observed upon
closer examination of single cells. For MRSA-86 mono-
culture, typical Staphylococcus clusters were identified,
with the average cluster size being 2–4 cocci (Figure 7).
Little to no membrane damage was observed.
For the PA-76/MRSA-35 co-culture PA-76 was found
as single cells or as doubles (Figure 7). No large PA-76
cellular aggregates were noted, as for mono-cultures.
The membranes of PA cells were largely intact with little
to no apparent damage. Among the images collected, weMRSA biofilm. PA-68, PA-76, MRSA-35, and MRSA-86 CFU/mL values
sted with CFU/mL values in 1:1 and 3:1 MRSA:PA co-cultures. Both
lectively the CFU/mL counts were, from greatest to least, MRSA-35
L), and PA-76 (2.07 x 109 CFU/mL).
Figure 5 1:1 Co-cultures show decreases in P. aeruginosa and MRSA counts with MRSA being the most affected. Large decreases in
CFU/mL counts were observed for both P. aeruginosa and MRSA upon co-culturing, with the largest decreases occurring for MRSA. Overall, PA-68
showed 1.66 and 5.81 magnitude decreases in CFU/mL counts upon co-culturing with MRSA-35 and MRSA-86 respectively. PA-76 showed 1.08
and 1.48 magnitude decreases in CFU/mL upon co-culturing with MRSA-35 and MRSA-86. MRSA-35 showed 33.33 and 5.61 magnitude decreases
in CFU/mL counts when co-cultured with PA-68 and PA-76 respectively. MRSA-86 showed 157.89 and 88.64 magnitude decreases in CFU/mL
counts when co-cultured with PA-68 and PA-76 respectively.
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MRSA-35 that had clearly lysed, possibly as a result of
the interaction with P. aeruginosa. Other than this oc-
currence, all MRSA-35 cells appeared in aggregates of
two or more cells with little to no membrane damage.
No cell aggregates were observed that contained both
PA-76 and MRSA-35, other than the one frame with
the lysed MRSA-35 cell. Thus, it would appear that the
competitive interaction that exists between these cells,
which likely reduced co-culture biofilm formation, oper-
ates outside of simple biocidal mechanisms.
Study of the P. aeruginosa isolates from dogs has the po-
tential to advance the understanding of both human and
animal wound infection pathogenesis, and contribute toFigure 6 3:1 Co-cultures show decreases in both P. aeruginosa and M
co-cultures. Compared to mono-culture counts, decrease in CFU/mL were
MRSA:PA ratios. MRSA counts were shown to be higher than after incubati
cell counts were lower than P. aeruginosa cell counts in all 3:1 co-culture cthe development of animal models that may resemble
spontaneous human infection. The studied P. aeruginosa
isolates from dogs have similar pathogenic phenotypes
and genotypes of human relevant strains. Hence, it is rea-
sonable to extrapolate the results obtained to humans.
Conclusions
The microtiter plate assay provides a good initial model for
testing the effects of protein coating on the production of
biofilm. In this study, it was observed that protein coating
led to enhanced biofilm production in monoculture bio-
films. This trend was not observed in co-culture. Among
the varying ratios of collagen: HA coatings, few definable
trends were found in the mono- and co-cultures. No singleRSA cell counts, with MRSA being less affected compared to 1:1
observed for both P. aeruginosa and MRSA upon co-culturing in 3:1
on as 3:1 co-cultures when compared to 1:1 co-culture counts. MRSA
ombinations.
Figure 7 Atomic force microscopy of P. aeruginosa and MRSA in mono- and co-culture on gelatin-coated mica. (A & B) Showing overview of
P. aeruginosa BK-76 mono-culture and two individual cells with flagella (C) showing MRSA M05-35 cell aggregation in mono-culture (D & E) showing
co-culturing of P. aeruginosa BK-76 +MRSA M05-35. (D) Shows an overview of the co-culture with P. aeruginosa BK-76 single and attached cells.
(E) Shows two attached P. aerugionsa BK-76 cells ‘attacking’ a single MRSA M05-35 cell with the appearance of spilled cytoplasmic contents.
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in biofilm formation, although collagen alone did seem
to produce slightly more biofilm biomass on average.
Co-culturing led to a decrease in biofilm production
compared to either mono-culture biofilm. Among the
co-cultures, no observable difference in biofilm was
produced in the 3:1 MRSA: PA co-culture compared tothe 1:1 co-cultures, aside from a few exceptions. The
Atomic Force Microscopy imaging was able to reveal
changes in cell packing between the mono- and co-
culturing of PA-76 and MRSA-35 and showed that the
competitive interaction between these P. aeruginosa
and MRSA likely operates outside of a simple biocidal
mechanism.
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